Geographic and climatic factors associated with exfoliation syndrome

Archives of Ophthalmology

Volumn 129, Issue 8, 2011, Pages 1053-1060

  Stein, Joshua D ^a   Pasquale, Louis R ^b   Talwar, Nidhi ^a   Kim, Denise S ^a   Reed, David M ^a   Nan, Bin ^d   Kang, Jae Hee ^c   Wiggs, Janey L ^b   Richards, Julia E ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLIMATE CHANGE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; EXFOLIATION SYNDROME; EYE CARE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SUN EXPOSURE; UNITED STATES;

AGED; CLIMATE; EXFOLIATION SYNDROME; FEMALE; GEOGRAPHY; GLAUCOMA, OPEN-ANGLE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 80051556462     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.191     Document Type: Article

References (67)

1. Ritch R. Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma. J Glaucoma. 1994;3(2):176-177.
2. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22(3):253-275. (Pubitemid 38401056)
3. Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development: five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg. 2001;27(12):1992-1998. (Pubitemid 33136181)
4. Shingleton BJ, Heltzer J, O'Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg. 2003;29(6):1080-1086. (Pubitemid 36759096)
5. Schlötzer-Schrehardt U, Naumann GO. A histopathologic study of zonular instability in pseudoexfoliation syndrome. Am J Ophthalmol. 1994;118(6):730-743. (Pubitemid 24378455)
6. Skuta GL, Parrish RK II, Hodapp E, Forster RK, Rockwood EJ. Zonular dialysis during extracapsular cataract extraction in pseudoexfoliation syndrome. Arch Ophthalmol. 1987;105(5):632-634. (Pubitemid 17061107)
7. Harnisch JP, Barrach HJ, Hassell JR, Sinha PK. Identification of a basement membrane proteoglycan in exfoliation material. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981;215(4):273-278. (Pubitemid 11137551)
8. Schlötzer-Schrehardt U, Dörfler S, Naumann GO. Immunohistochemical localization of basement membrane components in pseudoexfoliation material of the lens capsule. Curr Eye Res. 1992;11(4):343-355.
9. Uusitalo M, Kiveldä T, Tarkkanen A. Immunoreactivity of exfoliation material for the cell adhesion-related HNK-1 carbohydrate epitope. Arch Ophthalmol. 1993;111(10):1419-1423. (Pubitemid 23296790)
10. Tawara A, Fujisawa K, Kiyosawa R, Inomata H. Distribution and characterization of proteoglycans associated with exfoliation material. Curr Eye Res. 1996;15(11):1101-1111. (Pubitemid 26395268)
11. Sharma S, Chataway T, Burdon KP, et al. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res. 2009;89(4):479-485.
12. Ovodenko B, Rostagno A, Neubert TA, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48(4):1447-1457. (Pubitemid 351261324)
13. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992;110(12):1757-1762.
14. Schlötzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110(12):1752-1756.
15. Al-Ghadyan AA, Cotlier E. Rise in lens temperature on exposure to sunlight or high ambient temperature. Br J Ophthalmol. 1986;70(6):421-426. (Pubitemid 16114887)
16. Vessani RM, Ritch R, Liebmann JM, Jofe M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol. 2003;136(1):41-46. (Pubitemid 36794493)
17. Leibovitch I, Kurtz S, Shemesh G, et al. Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12(1):36-39. (Pubitemid 36228053)
18. Puustjärvi T, Blomster H, Kontkanen M, Punnonen K, Teräsvirta M. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242(9):749-754. (Pubitemid 39386374)
19. Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioǧlugil MO, Caǧlar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):677-683. (Pubitemid 40975492)
20. Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol. 2006;6:6.
21. Roedl JB, Bleich S, Reulbach U, et al. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm. 2007;114(5):571-575. (Pubitemid 46664043)
22. Aydoǧan Ozkan B, Yüksel N, Keskin G, et al. Homocysteine levels in plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome. Eur J Ophthalmol. 2006;16(4):542-547. (Pubitemid 44859661)
23. Cahill M, Early A, Stack S, Blayney AW, Eustace P. Pseudoexfoliation and sensorineural hearing loss. Eye (Lond). 2002;16(3):261-266. (Pubitemid 34618822)
24. Detorakis ET, Chrysochoou F, Paliobei V, et al. Evaluation of the acoustic function in pseudoexfoliation syndrome and exfoliation glaucoma: audiometric and tympanometric findings. Eur J Ophthalmol. 2008;18(1):71-76. (Pubitemid 351428552)
25. Shaban RI, Asfour WM. Ocular pseudoexfoliation associated with hearing loss. Saudi Med J. 2004;25(9):1254-1257. (Pubitemid 39334961)
26. Turacli ME, Ozdemir FA, Tekeli O, Gökcan K, Gerçeker M, Dürük K. Sensorineural hearing loss in pseudoexfoliation. Can J Ophthalmol. 2007;42(1):56-59. (Pubitemid 46408895)
27. Yazdani S, Tousi A, Pakravan M, Faghihi AR. Sensorineural hearing loss in pseudoexfoliation syndrome. Ophthalmology. 2008;115(3):425-429.
28. Tarkkanen A. Is exfoliation syndrome a sign of systemic vascular disease? Acta Ophthalmol. 2008;86(8):832-836.
29. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397-1400. (Pubitemid 47417481)
30. Challa P. Genetics of pseudoexfoliation syndrome. Curr Opin Ophthalmol. 2009;20(2):88-91.
31. Ringvold A, Blika S, Elsås T, et al. The prevalence of pseudoexfoliation in three separate municipalities of Middle-Norway: a preliminary report. Acta Ophthalmol Suppl. 1987;182:17-20. (Pubitemid 18028370)
32. Krause U, Alanko HI, Kärnä J, et al. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol Suppl. 1988;184:120-122.
33. Aström S, Lindén C. Incidence and prevalence of pseudoexfoliation and openangle glaucoma in northern Sweden, I: baseline report. Acta Ophthalmol Scand. 2007;85(8):828-831. (Pubitemid 350142803)
34. Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians. Trans Ophthalmol Soc U K. 1979;99(2):296-298. (Pubitemid 10074872)
35. Young AL, Tang WW, Lam DS. The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol. 2004;88(2):193-195. (Pubitemid 38142084)
36. World Health Organization. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Geneva, Switzerland: World Health Organization; 2006.
37. Beebe M, Dalton JA, Espronceda M, Evans DD, Glenn RL. CPT 2007 Professional Edition. Chicago, IL: American Medical Association Press; 2006.
38. Schneeweiss S, Doherty M, Zhu S, et al. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma. Dermatology. 2009;219(1):7-21.
39. Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc. 2008;139(1):23-30.
40. Cnaan A, Ryan L. Survival analysis in natural history studies of disease. Stat Med. 1989;8(10):1255-1268. (Pubitemid 19255873)
41. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
42. Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53(8):1711-1718. (Pubitemid 29530344)
43. Compare climates. Sperling's Best Places Web site. http://www.bestplaces. net/climate. Accessed June 2, 2011.
44. Aasved H. Prevalence of fibrillopathia epitheliocapsularis (pseudoexfoliation) and capsular glaucoma. Trans Ophthalmol Soc U K. 1979;99(2):293-295. (Pubitemid 10074871)
45. Arnarsson A, Damji KF, Sverrisson T, Sasaki H, Jonasson F. Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables. Acta Ophthalmol Scand. 2007;85(8):822-827. (Pubitemid 350142802)
46. Cashwell LF Jr, Shields MB. Exfoliation syndrome: prevalence in a southeastern United States population. Arch Ophthalmol. 1988;106(3):335-336. (Pubitemid 18081712)
47. Miyazaki M, Kubota T, Kubo M, et al. The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study. J Glaucoma. 2005;14(6):482-484. (Pubitemid 41682243)
48. Cursiefen C, Hammer T, Küchle M, Naumann GO, Schlötzer- Schrehardt U. Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion: a histopathologic and electron microscopic study. Acta Ophthalmol Scand. 2001;79(5):476-478. (Pubitemid 32962837)
49. Ritch R, Prata TS, de Moraes CG, et al. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol. 2010;88(1):91-95.
50. Saatci OA, Ferliel ST, Ferliel M, Kaynak S, Ergin MH. Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion. Int Ophthalmol. 1999;23(2):75-78. (Pubitemid 32041062)
51. Rudkin AK, Edussuriya K, Sennanayake S, et al. Prevalence of exfoliation syndrome in central Sri Lanka: the Kandy Eye Study. Br J Ophthalmol. 2008;92(12):1595-1598.
52. Arvind H, Raju P, Paul PG, et al. Pseudoexfoliation in South India. Br J Ophthalmol. 2003;87(11):1321-1323. (Pubitemid 37452551)
53. Rao RQ, Arain TM, Ahad MA. The prevalence of pseudoexfoliation syndrome in Pakistan: hospital based study. BMC Ophthalmol. 2006;6:27.
54. Topouzis F, Wilson MR, Harris A, et al. Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol. 2007;144(4):511-519.
55. Ball SF. Exfoliation syndrome prevalence in the glaucoma population of South Louisiana. Acta Ophthalmol Suppl. 1988;184:93-98.
56. Krause U, Helve J, Forsius H. Pseudoexfoliation of the lens capsule and liberation of iris pigment. Acta Ophthalmol (Copenh). 1973;51(1):39-46.
57. Sveinsson K. The frequency of senile exfoliation in Iceland: fibrillopathy or pseudoexfoliation. Acta Ophthalmol (Copenh). 1974;52(5):596-602.
58. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr Opin Ophthalmol. 2008;19(2):95-101. (Pubitemid 351322810)
59. Forsius H, Luukka H. Pseudoexfoliation of the anterior capsule of the lens in Lapps and Eskimos. Can J Ophthalmol. 1973;8(2):274-277.
60. Blackburn DG. Why race is not a biological concept. In: Lang B, ed. Race and Racism in Theory and Practice. New York, NY: Rowman & Littlefield Publishers Inc; 2000:3-26.
61. Resnikoff S, Filliard G, Dell'Aquila B. Climatic droplet keratopathy, exfoliation syndrome, and cataract. Br J Ophthalmol. 1991;75(12):734-736.
62. Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Surv Ophthalmol. 1992;36(4):241-253.
63. Taylor HR. Pseudoexfoliation, an environmental disease? Trans Ophthalmol Soc U K. 1979;99(2):302-307. (Pubitemid 10074874)
64. Faulkner HW. Pseudo-exfoliation of the lens among the Navajo Indians. Am J Ophthalmol. 1971;72(1):206-207.
65. Zuclich JA. Ultraviolet-induced photochemical damage in ocular tissues. Health Phys. 1989;56(5):671-682. (Pubitemid 19158645)
66. Taylor HR, Hollows FC, Moran D. Pseudoexfoliation of the lens in Australian Aborigines. Br J Ophthalmol. 1977;61(7):473-475. (Pubitemid 8157625)
67. Forsius H, Forsman E, Fellman J, Eriksson AW. Exfoliation syndrome: frequency, gender distribution and association with climatically induced alterations of the cornea and conjunctiva. Acta Ophthalmol Scand. 2002;80(5):478-484. (Pubitemid 35243851)